Microfluidics Market 2019: Comprehensive Analysis on Business Summary, Product Opportunity and Current Industry Development 2024

(MENAFN- The Express Wire) Microfluidics Market 2019: Comprehensive Analysis on Business Summary, Product Opportunity and Current Industry Development 2024

Posted on Nov 8 2019 7:08 AM

"This report studies the global Microfluidics market size, manufacturing status and forecast, competition landscape and growth opportunity. This research report classifies the global Microfluidics market by companies, region, type and end-use industry.
"

 ' Microfluidics Market'research report highlights existing dynamics and growths during the forecast period 2019-2024. The report incorporates detailed analysis of the market development drivers as well as the preventing factors in the Microfluidics market. The scope of the report covers an extensive estimation pertaining to the winning essentials and participant schemes through a presentation of the segmentation of market in the report.

Following Companies Are Covered by Microfluidics Market

• Abbott Laboratories


• F. Hoffmann


• LA Roche Ltd


• Agilent Technologies


• Danaher Corporation (Cepheid)


• Thermo Fisher Scientific Inc.


• Bio


• Rad Laboratories Inc.


• PerkinElmer Inc.


• FluIdigm Corporation


• Dolomite Microfluidics (Blacktrace Holdings Ltd)


• Micronit Microfluidics

Get a Sample Copy of the Report - https://www.absolutereports.com/enquiry/request-sample/13999539

Market Overview:

• The global microfluidics market was valued at USD 4,748.18 million in 2018, and is estimated to be valued at USD 13,348.29 million in 2024, witnessing a CAGR of 18.80%. Factors that are propelling the growth of the market include rising demand for point-of-care testing, increasing Incidences of chronic diseases, faster turn-around time for analysis, and improved portability of devices.


• POC testing allows healthcare experts to diagnose a patient in the physician's office, in an ambulance, at home, field, or in the hospital. Microfluidic technology-assisted devices are being employed for POC testing, as they require small volumes of samples and use micro-fabricated channels to analyze these samples. POC testing devices are already popular in glucose, blood, hemoglobin, and HIV testing domains. Future POC testing devices are likely to focus more on antibiotics therapies and cancer.


• With the wide range of applications offered by these devices, microfluidic technology-based POC testing devices have immense potential in the developing and developed countries, as the percentage of population affected by these diseases is high.

Scope of the Report:

• This report estimates the global microfluidics market size by summing up the value of market segments divided on the basis of type of component, application, and materials. Further, each of these segments are sub-divided to cover all relevant categories.

Why there is Need of Microfluidics Market Research?

• To determine trades anticipation, consumption trend, and need of market.


• To keep up competitiveness over applicants performing in the Microfluidics market.


• To get detailed knowledge of the market which helps in terms of decision- making.


• To advance insight into industrial, social, methodological, and legal aspects of the market.


• To perceive the detailed market size derived by analyzing upward and downward moment of Microfluidics market trends.


• To get knowledge of worldwide marketplaces and their leveling trading environments, effectiveness, and inclinations.

For More Information or Query or Customization Before Buying, Visit at - https://www.absolutereports.com/enquiry/pre-order-enquiry/13999539

Key Market Trends:
Clinical Diagnostics is Expected to hold its Highest Market Share in the Application Segment
In the application segment of the microfluidics market, clinical diagnostics is believed to have the largest market size and is expected to witness a CAGR of 18.80% during the forecast period.
A significant application area for microfluidic technology is clinical diagnostics. Specifically for clinical diagnostics, diseases, including toxicity, can be diagnosed by performing various biochemical analyzes and by observation of symptoms. The biochemical changes in the patient's blood can signal organ damage or dysfunction, prior to observable microscopic cellular damages or other symptoms.
So there has been a large demand for the development of an easy-to-handle and inexpensive clinical diagnostic biochip using fully integrated plastic microfluidic chips, which have the sampling/identifying capability of fast and reliable measurements of metabolic parameters from a human body with minimum invasion. Thus, the growth of clinical diagnostics is expected to fuel the market's growth.
North America Dominates the Market and is Expected to do the Same in the Forecast Period
The North American region holds the largest market share in the market for microfluidics. This is attributed to factors, such as the well-established healthcare system, along with better reimbursement policies, and the higher adoption of novel therapeutics among the general population. Microfluidics is a vastly growing field in the United States, in terms of high budget sanctions for R & D. Molecular diagnostics and point-of-care diagnostics widely use microfluidic technology for various applications, and hence, they occupy a major market share in the United States. Owing to this, the United States has the largest market share of 88% in North America, and is expected to grow at a rate of 18.8% over the forecast period.

Reasons to Purchase this Report

• How the developing pattern towards maintainability goes about as a driver to the worldwide Microfluidics market situation?


• Analyzing different points of view of the market with the assistance of Porter's five powers investigation


• Which solutions and end-user vertical is predictable to overlook the Microfluidics market?


• Which regions are relied upon to observe the fastest development during the prediction period?


• Identify the most recent advancements, market shares and strategies utilized by the significant market players.

Purchase this Report (Price 4250 USD for single user license) - https://www.absolutereports.com/purchase/13999539

Detailed TOC of Microfluidics Market Report 2019-2024:

1 INTRODUCTION
1.1 Study Deliverables
1.2 Study Assumptions
1.3 Scope of the Study
2 RESEARCH METHODOLOGY
3 EXECUTIVE SUMMARY
4 MARKET DYNAMICS
4.1 Market Overview
4.2 Market Drivers
4.2.1 Increasing Demand for Point-of-care Testing
4.2.2 Increasing Incidences of Chronic Diseases
4.2.3 Faster Turn-around Time for Analysis and Improved Portability of Devices
4.3 Market Restraints
4.3.1 Need for Specialized Skills in Operations and Complex Regulatory Approval Process
4.3.2 Low Adoption in Developing Countries due to High Prices
4.4 Porter's Five Forces Analysis
4.4.1 Threat of New Entrants
4.4.2 Bargaining Power of Buyers/Consumers
4.4.3 Bargaining Power of Suppliers
4.4.4 Threat of Substitute Products
4.4.5 Intensity of Competitive Rivalry
5 MARKET SEGMENTATION
5.1 Component
5.1.1 Microfluidic Chips
5.1.2 Micro Pumps
5.1.3 Micro Needles
5.1.4 Other Components
5.2 Application
5.2.1 Drug Delivery
5.2.2 High-throughput Screening
5.2.3 Point-of-Care Diagnostics
5.2.4 Lab Analytics
5.2.4.1 Proteomics
5.2.4.2 Genomics
5.2.4.3 Cell-based Assay
5.2.4.4 Capillary Electrophoresis
5.2.5 Clinical Diagnostics
5.3 Material
5.3.1 Polymer
5.3.2 Silicone
5.3.3 Glass
5.4 Geography
5.4.1 North America
5.4.1.1 United States
5.4.1.2 Canada
5.4.1.3 Mexico
5.4.2 Europe
5.4.2.1 Germany
5.4.2.2 United Kingdom
5.4.2.3 France
5.4.2.4 Italy
5.4.2.5 Spain
5.4.2.6 Rest of Europe
5.4.3 Asia-Pacific
5.4.3.1 China
5.4.3.2 Japan
5.4.3.3 India
5.4.3.4 Australia
5.4.3.5 South Korea
5.4.3.6 Rest of Asia-Pacific
5.4.4 Middle East & Africa
5.4.4.1 GCC
5.4.4.2 South Africa
5.4.4.3 Rest of Middle East & Africa
5.4.5 South America
5.4.5.1 Brazil
5.4.5.2 Argentina
5.4.5.3 Rest of South America
6 COMPETITIVE LANDSCAPE
6.1 Company Profiles
6.1.1 Abbott Laboratories
6.1.2 F. Hoffmann-LA Roche Ltd
6.1.3 Agilent Technologies
6.1.4 Danaher Corporation (Cepheid)
6.1.5 Thermo Fisher Scientific Inc.
6.1.6 Bio-Rad Laboratories Inc.
6.1.7 PerkinElmer Inc.
6.1.8 FluIdigm Corporation
6.1.9 Dolomite Microfluidics (Blacktrace Holdings Ltd)
6.1.10 Micronit Microfluidics
7 MARKET OPPORTUNITIES AND FUTURE TRENDS

MENAFN08112019007010266ID1099242797

Legal Disclaimer:
MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.